“…However, recent data obtained using mice genetically modified to be deficient in one or more complement components have identified a vital role for classical pathway activity in innate immunity to S. pneumoniae and other pathogens and have demonstrated the classical pathway to be activated by a variety of innate immune mediators, including pentraxins, natural IgM, and the cell surface lectin SIGN-R1 (7,11,18,29,41,44,48,49). An important role for the classical pathway in immunity to S. pneumoniae is also supported by the limited clinical data available on infections in patients with complement deficiencies, as patients with defects in the classical pathway are at high risk of S. pneumoniae infections (10,27,28). In contrast, patients with complement deficiencies affecting the alternative pathway have a massively increased incidence of infections with Neisseria species rather than S. pneumoniae (10).…”